Insider · CIK 0001451495

Moran Sean F.

CIK 0001451495 Name as filed on the most recent filing

Filed as Moran Sean F. (55)

68 transaction lines · from 55 filings · filed 2009-03-17 to 2026-08-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

68 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-07 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 120,971, disposed Open Form 4 filing 0001193125-26-342479
2026-02-13 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 36,588, disposed Open Form 4 filing 0001193125-26-057168
2025-10-24 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 220,937, disposed Open Form 4 filing 0001193125-25-251635
2025-02-14 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 24,446, disposed Open Form 4 filing 0000950170-25-022514
2024-06-18 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 82,479, disposed Open Form 4 filing 0000950170-24-075075
2024-06-17 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 314,789, disposed Open Form 4 filing 0000950170-24-075075
2024-06-14 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 2 lines 466,569, disposed Open Form 4 filing 0000950170-24-075075
2022-08-10 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 5,198, acquired Open Form 4 filing 0001209191-22-045137
2022-05-16 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 3,600, acquired Open Form 4 filing 0001209191-22-029031
2022-03-10 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 5,550, acquired Open Form 4 filing 0001209191-22-017781
2020-12-21 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 153,125, disposed Open Form 4 filing 0001209191-20-064849
2020-12-18 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 75,054, disposed Open Form 4 filing 0001209191-20-064849
2020-12-16 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 48,628, disposed Open Form 4 filing 0001209191-20-064437
2019-05-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 712, acquired Open Form 4 filing 0001209191-19-029556
2019-03-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 10,005, acquired Open Form 4 filing 0001209191-19-019352
2018-05-15 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 23,080, acquired Open Form 4 filing 0001209191-18-030106
2018-03-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 20,460, acquired Open Form 4 filing 0001209191-18-019494
2017-11-10 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 10,560, acquired Open Form 4 filing 0001209191-17-060218
2017-08-11 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 14,775, acquired Open Form 4 filing 0001209191-17-048508
2017-05-11 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 20,262, acquired Open Form 4 filing 0001209191-17-031793
2017-03-13 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 19,200, acquired Open Form 4 filing 0001209191-17-020027
2016-12-02 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 10,800, acquired Open Form 4 filing 0001209191-16-152835
2016-09-08 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 157,696, acquired Open Form 4 filing 0001209191-16-140481
2016-08-26 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 70,168, acquired Open Form 4 filing 0001209191-16-138734
2016-08-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 226,200, acquired Open Form 4 filing 0001209191-16-137737
2016-08-17 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 267,832, acquired Open Form 4 filing 0001209191-16-137737
2016-05-19 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 64,583, acquired Open Form 4 filing 0001209191-16-121472
2016-05-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 71,700, acquired Open Form 4 filing 0001209191-16-121157
2015-12-11 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,559, acquired Open Form 4 filing 0001209191-15-084570
2015-12-10 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,611, acquired Open Form 4 filing 0001209191-15-084414
2015-12-09 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,670, acquired Open Form 4 filing 0001209191-15-084155
2015-12-08 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,682, acquired Open Form 4 filing 0001209191-15-083872
2015-12-07 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,689, acquired Open Form 4 filing 0001209191-15-083639
2015-12-04 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,720, acquired Open Form 4 filing 0001209191-15-083458
2015-12-02 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,790, acquired Open Form 4 filing 0001209191-15-083073
2015-11-24 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,670, acquired Open Form 4 filing 0001209191-15-081891
2015-11-20 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,548, acquired Open Form 4 filing 0001209191-15-081424
2015-11-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,565, acquired Open Form 4 filing 0001209191-15-080851
2015-11-17 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,583, acquired Open Form 4 filing 0001209191-15-080482
2015-11-16 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 3,372, acquired Open Form 4 filing 0001209191-15-080165
2015-09-16 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 10,605, acquired Open Form 4 filing 0001209191-15-070890
2015-09-15 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 10,720, acquired Open Form 4 filing 0001209191-15-070617
2015-09-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 9,820, acquired Open Form 4 filing 0001209191-15-070447
2015-09-11 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 9,234, acquired Open Form 4 filing 0001209191-15-070296
2015-08-21 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,879, acquired Open Form 4 filing 0001209191-15-067342
2015-08-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,916, acquired Open Form 4 filing 0001209191-15-066751
2015-06-09 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 19,500, acquired Open Form 4 filing 0001209191-15-051417
2014-12-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 63,168, acquired Open Form 4 filing 0001209191-14-077243
2014-12-17 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 4,475, acquired Open Form 4 filing 0001209191-14-076518

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 55
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Moran Sean F., insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001451495

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.